Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
ActiveAtlas Opportunity Score 64/100
SC-MUSC-SCTR-STEP-ROLLING-2026South Carolina

South Carolina MUSC SCTR Translational Entrepreneurship Pilot (STEP) Grant — Rolling 2026

MUSC's South Carolina Clinical & Translational Research Institute accepts Translational Entrepreneurship Pilot (STEP) applications on a rolling basis for interdisciplinary translational projects with commercialization potential. Awards provide up to $10,000 in direct costs for 12 months.

FundingUp to $10,000 in direct costs for a 12-month project period.
DeadlineRolling basis; the current SCTR page publishes no fixed deadline, closing time, or timezone. Applicants should confirm current availability in InfoReady.
Last verifiedOctober 1, 2026
Required next actionConfirm current STEP-specific PI eligibility and funding availability in InfoReady, then prepare the required application with a concrete Path to Commercialization.

Broad Eligibility

MUSC-led interdisciplinary translational entrepreneurship projects with substantial IP/commercialization potential. Current STEP-specific PI eligibility should be confirmed in InfoReady or with SCTR because the detailed public eligibility language is Discovery-specific.

Atlas Analysis

The SCTR Translational Entrepreneurship Pilot supports innovative interdisciplinary pilot projects with substantial intellectual-property or commercialization potential. Applications are accepted on a rolling basis, and awards provide up to $10,000 in direct costs for a 12-month project period. Projects should present a clear commercialization pathway rather than routine implementation or purchasing.

Opportunity Overview

The South Carolina Clinical & Translational Research Institute (SCTR) Translational Entrepreneurship Pilot (STEP) Grant supports innovative interdisciplinary translational projects with substantial intellectual-property or commercialization development potential.

Funding and Deadline

STEP provides up to $10,000 in direct costs for a 12-month project period. The current SCTR Pilot Funding page states that STEP applications are accepted on a rolling basis. No fixed deadline, closing time, or timezone is published, so applicants should confirm current availability in InfoReady before submission.

Program Focus

Projects should have a credible path toward commercialization or technology transfer. The published application structure asks applicants to describe a Path to Commercialization, including potential routes such as startup formation, SBIR/STTR funding, an industry partner, licensing, or another concrete commercialization pathway.

Application Requirements

The current SCTR page lists a Specific Aims section, a three-page Research Strategy, Path to Commercialization information, Literature Cited when applicable, early-stage-investigator material when applicable, a one-page Timeline, NIH biosketches, a detailed PHS 398 Budget and Budget Justification, and a Progress Report when applicable. A Record of Innovation statement is recommended. Submission is through InfoReady.

Allowable and Unallowable Costs

SCTR’s current pilot guidance lists allowable research costs including appropriately justified personnel, research supplies, equipment under limited circumstances, participant compensation and transportation, inpatient and outpatient care, statistical or computational services, and potential subawards. Unallowable costs include student tuition, fees and health insurance; ancillary personnel such as mentors and administrative assistants; general office supplies; general-purpose equipment unless specifically justified; dues; conference travel; publication and subscription costs; mailing; rent; and facilities and administrative or other indirect costs.

The public SCTR page reviewed by Atlas does not state a mandatory match or cost-share requirement for STEP.

Atlas Analysis

Atlas Opportunity Score: 64/100. STEP is a legitimate South Carolina healthcare-innovation funding pathway, but its value depends on a project having genuine new intellectual-property or commercialization development rather than merely deploying an existing commercial product.

N9+ Fit Score: 25/100, conditional. N9+ should not be positioned as a routine purchase or promotional deployment under this mechanism. A potential fit would require an MUSC-led project that develops genuinely novel intellectual property, integration, workflow, research methodology, or commercialization work around remote examination or telehealth technology and satisfies SCTR’s commercialization expectations.

QC Healthcare Fit: 5/100. This mechanism is translational entrepreneurship funding rather than a staffing or clinical-services procurement.

Direct-vendor disposition: Do not treat STEP as a direct Dr. Miltie submission. Any Dr. Miltie role would need to be subordinate to an eligible MUSC-led project and consistent with institutional conflict-of-interest, IP, procurement, and budget rules.

Eligibility Note

SCTR states generally that its pilot opportunities require interdisciplinary collaboration. The current public page’s detailed PI-eligibility language is written specifically for the Discovery mechanism, so STEP applicants should confirm the current STEP-specific PI requirements in InfoReady or directly with SCTR rather than assuming Discovery eligibility language applies unchanged.

Contacts

SCTR lists Sydney Bollinger at bollinger@musc.edu for InfoReady and program questions. The SCTR Office of Science Development may be reached at sctr-sdo@musc.edu.

Next Action

Prospective MUSC applicants should confirm current STEP-specific PI eligibility and funding availability in InfoReady, then build a project with a defensible commercialization pathway and project-specific budget.

Official source: MUSC SCTR Pilot Funding.

Source verificationReferenced source · research.musc.eduAtlas last verified this record October 1, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗